| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/25/2008 | US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/25/2008 | US20080233138 Coccidiosis Poultry Vaccine |
| 09/25/2008 | US20080233137 Block the inflammatory and immunomodulatory activity mediated by endogenous C5a; Adult Respiratory Distress Syndrome (ARDS), severe tissue damage following thrombotic events such as heart attacks and stroke, inflammatory bowel diseases and rheumatoid arthritis |
| 09/25/2008 | US20080233136 Biologically Active Peptides |
| 09/25/2008 | US20080233134 Antibodies That Specifically Bind to Chemokine Beta-4 |
| 09/25/2008 | US20080233133 Specified complementary determining region (CRD) amino acid sequences; specific binding activity for a cryptic collagen epitope; angiogenesis inhibition, antimetastasis, and tumor-targeted therapy uses |
| 09/25/2008 | US20080233132 Immunotherapy with myelin repair; immunoglobulins; autoimmune disorders |
| 09/25/2008 | US20080233131 Vaccine |
| 09/25/2008 | US20080233130 Immunoglobulin variable domain; tumor necrosis factor; competitve binding; surface plasmon resonance; treating allergic hypersensitivity |
| 09/25/2008 | US20080233129 Ligand that has binding specificity for IL-4 and/or lL-13 |
| 09/25/2008 | US20080233128 Treatment of Viral Infections |
| 09/25/2008 | US20080233127 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 09/25/2008 | US20080233126 G Proteins, Polynucleotides Encoding the Same and Utilization Thereof |
| 09/25/2008 | US20080233125 Antibodies target laminin 5 alpha 3 G4-G5 domain |
| 09/25/2008 | US20080233124 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/25/2008 | US20080233123 Polypeptide from haemophilus influenzae |
| 09/25/2008 | US20080233122 Complementarity determining regions; immunoglobulins; cell line, host cells; transgenic animals, plants |
| 09/25/2008 | US20080233121 Therapeutic treatments based on administration of small RNA fragments |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233119 Modulating death receptor 3 and/or CD30 function; interleukin expression inhibition |
| 09/25/2008 | US20080233118 Macrophage colony stimulating factor (M-Csf); monoclonal antibodies; atherosclerosis, HIV; kits |
| 09/25/2008 | US20080233117 Reducing tumor growth |
| 09/25/2008 | US20080233116 Human monoclonal antibodies to CTLA-4 |
| 09/25/2008 | US20080233115 Interleukins; cytokines; monoclonal antibodies; bioconjugation; toxic shock syndrome |
| 09/25/2008 | US20080233114 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 09/25/2008 | US20080233113 Cardiovascular conditions, ischemia-reperfusion injury, atherosclerosis, inflammatory gastrointestinal disorder, pulmonary condition, musculoskeletal conditions, renal conditions, skin conditions, organ or tissue transplants, nervous system disorders |
| 09/25/2008 | US20080233112 Treatment of Diseases |
| 09/25/2008 | US20080233111 DNAX interferon-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation, cell proliferative and viral infection |
| 09/25/2008 | US20080233110 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2008 | US20080233109 Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof |
| 09/25/2008 | US20080233108 Methods for detecting and inhibiting angiogenesis using antagonists |
| 09/25/2008 | US20080233107 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide |
| 09/25/2008 | US20080233106 Markers for labour |
| 09/25/2008 | US20080233105 Compositions and methods for preventing or treating a viral infection |
| 09/25/2008 | US20080233095 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 09/25/2008 | US20080233083 Methods and Compositions for Vaccination of Animals with Prrsv Antigens with Improved Immunogenicity |
| 09/25/2008 | US20080233053 Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients |
| 09/25/2008 | US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy |
| 09/25/2008 | US20080229609 Preservation by Vaporization |
| 09/25/2008 | CA2684578A1 Chimeric antigens |
| 09/25/2008 | CA2684569A1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 09/25/2008 | CA2684321A1 Compositions comprising pkac fragments and uses thereof for inhibiting akt1, p70s6k or abl activity |
| 09/25/2008 | CA2682212A1 Anti-sclerostin antibodies |
| 09/25/2008 | CA2681743A1 Stable antibody formulations |
| 09/25/2008 | CA2681420A1 P38 inhibitors |
| 09/25/2008 | CA2681246A1 Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer |
| 09/25/2008 | CA2681130A1 Novel human anti-r7v antibodies and uses thereof |
| 09/25/2008 | CA2681035A1 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 09/25/2008 | CA2680876A1 Oral vaccine |
| 09/25/2008 | CA2680854A1 Treatment method using egfr antibodies and src inhibitors and related formulations |
| 09/25/2008 | CA2680368A1 A method of treating malignant mesothelioma |
| 09/25/2008 | CA2680111A1 Uses of monoclonal antibody 8h9 |
| 09/25/2008 | CA2677733A1 Conjugates of synthetic tlr agonists and uses therefor |
| 09/25/2008 | CA2676775A1 Flavivirus vaccine vector against influenza virus |
| 09/25/2008 | CA2658508A1 Method of protecting against staphylococcal infection |
| 09/25/2008 | CA2656606A1 Anthrax carbohydrates,synthesis and uses thereof |
| 09/25/2008 | CA2653226A1 Liposomes and immunopotentiating compositions containing the same |
| 09/24/2008 | EP1972690A1 Desaturase antigen of mycobacterium tuberculosis |
| 09/24/2008 | EP1972638A1 Remedies for juvenile chronic arthritis and related diseases |
| 09/24/2008 | EP1972348A1 Novel vaccine composition for the treatment of respiratory infectious diseases |
| 09/24/2008 | EP1972347A1 Stable vaccine powder formulations |
| 09/24/2008 | EP1972194A1 Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 09/24/2008 | EP1971680A1 Method for generating dendritic cells employing decreased temperature |
| 09/24/2008 | EP1971403A1 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 09/24/2008 | EP1971402A1 Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 09/24/2008 | EP1971393A2 Method and device for transdermal immunization |
| 09/24/2008 | EP1971371A2 Cancer therapies and pharmaceutical compositions used therein |
| 09/24/2008 | EP1971367A2 Methods and compositions for needleless delivery of binding partners |
| 09/24/2008 | EP1971366A2 Human anti-il-23 antibodies, compositions, methods and uses |
| 09/24/2008 | EP1765294B1 Nucleic acid microspheres, production and delivery thereof |
| 09/24/2008 | EP1601374B1 Compositions and methods for diagnosing and treating an inflammation |
| 09/24/2008 | EP1385544B1 Humanized antibodies |
| 09/24/2008 | EP0979272B1 Strl33, a human fusion accessory factor associated with hiv infection |
| 09/24/2008 | CN101273064A Anti-TrkB monoclonal antibodies and uses thereof |
| 09/24/2008 | CN101273055A Novel method for preventing or treating m tuberculosis infection |
| 09/24/2008 | CN101272800A Cupredoxin derived transport agents and methods of use thereof |
| 09/24/2008 | CN101272766A Composition for administration to mammals or humans |
| 09/24/2008 | CN101270155A Method for assembling foot and mouth disease virus hollow capsid in insect with acidproof improvement |
| 09/24/2008 | CN101269218A Fortifier, special bait, injection for bleeding disease immunity of Chinese idle and novel immunity method |
| 09/24/2008 | CN101269214A Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 09/23/2008 | US7427670 Cytochrome P450 24 (CYP24) monoclonal antibody and methods and uses thereof |
| 09/23/2008 | US7427668 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 09/23/2008 | US7427660 Tumor antigen |
| 09/23/2008 | US7427658 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/23/2008 | US7427655 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 09/23/2008 | US7427639 β2-adrenergic receptor agonists |
| 09/23/2008 | US7427629 Immunostimulatory compositions and methods of stimulating an immune response |
| 09/23/2008 | US7427589 Administering substance that inhibits a pro-inflammatory cytokine for prevention or reduction of scar tissue and/or adhesion formation |
| 09/23/2008 | US7427498 Composition, methods and reagents for the synthesis of a soluble form of human PHEX |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427471 Modified “S” antibodies |
| 09/23/2008 | US7427469 Method of treating cytomegalovirus with DC-SIGN blockers |
| 09/23/2008 | US7427468 Anti-TSG101 antibodies and their uses for treatment of viral infections |
| 09/23/2008 | US7427405 Immunostimulatory oligonucleotide multimers |
| 09/23/2008 | US7427404 immunologically active and having reduced or no toxicity; decreased histamine sensitivity activity |
| 09/23/2008 | US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 09/23/2008 | US7427402 for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis; treatment to prevent such skin inflammatory disorders using antagonists of IL- 17A, IL-17F, IL-19, and/or IL-23 |
| 09/23/2008 | US7427401 Method of modulating leukemic cell and eosinphil activity with monoclonal antibodies |
| 09/23/2008 | US7427400 Administering antibody or a fragment thereof that binds to a human homolog of frizzled, to inhibit the proliferation of cancer cells |
| 09/23/2008 | US7427399 Antibodies and related molecules that bind to 161P2F10B proteins |